Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers [Phase 2, Phase 3]
Phase 2/3 trial evaluating atezolizumab and/or bevacizumab with or without standard chemotherapy as second-line treatment for advanced head …
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era [Phase 3]
A Phase 3 trial evaluating concurrent chemotherapy with intensity-modulated radiotherapy for intermediate-risk nasopharyngeal carcinoma has …
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: PD-1 Monoclonal Antibody Combined With Gemcitabine and Cisplatin Followed by Selective Radiotherapy for Unresectable Locally Recurrent NPC [Phase 2]
A Phase 2 clinical trial evaluating a PD-1 monoclonal antibody in combination with gemcitabine and cisplatin, followed by selective radiothe…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC [Phase 2]
A phase 2 trial evaluating low-dose radiotherapy combined with toripalimab and chemotherapy for recurrent or metastatic nasopharyngeal carci…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating TQB2618 in combination with Penpulimab for recurrent/metastatic nasopharyngeal carcinoma has completed. Sponsor: Ch…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Upfront Neck Dissection Before Radiotherapy in Stage N3 Nasopharyngeal Carcinoma: A Retrospective Study
This completed retrospective study assesses upfront neck dissection before radiotherapy for patients with stage N3 nasopharyngeal carcinoma.…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: IC Plus Low-dose Radiation Plus Cadonilimab in LANPC [Phase 3]
A Phase 3 trial from Sun Yat-sen University is evaluating Cadonilimab in combination with low-dose radiotherapy and chemotherapy for nasopha…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma [Phase 2]
This clinical trial update states a Phase 2 study of Becotatug Vedotin as adjuvant therapy for high-risk Nasopharyngeal Carcinoma, currently…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001) [Phase 1, Phase 2]
Genmab's PRO1160 (GEN1160) Phase 1/2 trial in relapsed or refractory non-Hodgkin lymphoma has been terminated; the study also included renal…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Combining MRI and CEUS to Diagnose Small Cervical Lymph Node Metastases in NPC Patients [NA]
A completed study evaluating MRI combined with contrast-enhanced ultrasound to detect small cervical lymph node metastases in patients with …
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC. [Phase 2]
Phase 2 clinical trial evaluating Envafolimab with chemoradiotherapy and recombinant human endostatin for locally advanced nasopharyngeal ca…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: MRG003 Combined With Immunotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial [Phase 2]
A Phase II clinical trial evaluating MRG003 in combination with immunotherapy for recurrent/metastatic nasopharyngeal carcinoma, currently n…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients [Phase 3]
Phase 3 trial comparing concurrent chemoradiotherapy with and without adjuvant chemotherapy for locally advanced nasopharyngeal carcinoma; t…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating short-course tislelizumab in combination with chemoradiotherapy for nasopharyngeal carcinoma; the study is not yet …
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors. [Phase 1]
A Phase 1 study evaluating DKY709 alone or in combination with PDR001 in patients with advanced solid tumors. The enrolled diseases include …
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: EBV Specific Cytokine Secreting TCR-T Cells in the Treatment of EBV-Positive Metastatic/Refractory Nasopharyngeal Carcinoma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating EBV-specific cytokine-secreting TCR-T cells for EBV-positive metastatic or refractory nasopharyngeal c…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC) [Phase 2]
Phase 2 trial evaluating nivolumab with chemoradiation for stage II-IVB nasopharyngeal carcinoma completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers [Phase 1]
Phase 1 study assessing safety and early efficacy of KFA115 alone and in combination with pembrolizumab in select advanced cancers; the tria…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Consolidation Pembrolizumab After Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial assessing consolidation pembrolizumab after chemoradiotherapy in locally advanced nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer [Phase 2]
Phase 2 trial (NEO-SPACE) evaluating pembrolizumab with chemoradiation in nasopharyngeal carcinoma has results posted.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2]
This document notes the completion of a Phase 2 trial evaluating induction chemotherapy with nab-paclitaxel, cisplatin, and fluorouracil for…
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial of INCB099318 in participants with advanced solid tumors has been terminated. The update reports safety, tolerability…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors [Phase 1]
This Phase 1 trial evaluated safety and preliminary effectiveness of BGB-A445 in combination with tislelizumab in participants with advanced…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Individualized Elective Neck Irradiation in NPC Patients [Phase 3]
A Phase 3 clinical trial update shows a study evaluating individualized elective neck irradiation for nasopharyngeal carcinoma is currently …
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinomar
Clinical trial update on precise guidance of adaptive radiotherapy for nasopharyngeal carcinoma; the study is not yet recruiting.